CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


<
Abbott Laboratories  (ABT)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 



 

Abbott Laboratories

ABT's Financial Statements and Analysis




Abbott Laboratories reported in II. Quarter net earnings per share of $0.16 a decrease by 0 % year on year from $0.41 and decline of 0 % from $0.24 earned in I. Quarter (Mar 31 2017).

Abbott Laboratories's Revenue rose by % in II. Quarter (Jun 30 2017) year on year, to $6,637 million and advanced by 4.77 % sequentially.


Abbott Laboratories is Expected to report next financial results on October 23, 2017.
More on ABT's Income Statement

II. Quarter
Earnings Per Share Revenues
$ 0.16 $  6,637 Mill
$-0.25     -60.98 % $+1,304M     +24.45 %
You need to upgrade your Flash Player


       
  • Established Pharmaceutical Products 24.64% Y/Y,
• Pediatric Nutritionals 3.95% Y/Y,
• Nutritionals 0.11% Y/Y
   
     
       
  • Adult Nutritionals -1.92% Y/Y,
• Endovascular -0.77% Y/Y,
• Vascular -7.95% Y/Y,
• Diagnostics -2.03% Y/Y,
• Other -10.06% Y/Y
   
     


ABT's Segments

ABT's NET INCOME

Abbott Laboratories's net income of $283 million in II. Quarter decreased by -53.98 % from net earnings of $615 million achieved in II. Quarter a year ago.

Sequentially net earnings fell by -32.46 % from net income of $419.00 million realized in previous quarter.

More on ABT's Growth

Abbott Laboratories Income Growth by Division

• Vascular -14.64% Y/Y,
• Diagnostics -0.97% Y/Y • Established Pharmaceutical Products 10.63% Y/Y,
• Nutritionals 24.39% Y/Y

Inventories Inventories grew by 28.08 % to $3,603 million from II. Quarter a year ago, sequentially inventories fell by -9.81 %. ABT's Cash flow In II. Quarter company's net cash flow was $969 million, capital expenditures fell by 3.24%, to $-255 millions compare to same quarter a year ago and rose by -6.25% from I. Quarter (Mar 31 2017).

More on ABT's Cash flow Statement



Abbott Laboratories payed out dividend of $1.05 per share in last 52 weeks representing 145.83 % of net earning per share in trailing twelve-month period.

During the same period Abbott Laboratories earned $ 2.29 cash per share, on a free-cash flow basis 317.66 % of net earning per share.

Book value fell by -0.02 % sequentially to $18.18 per share.
Tangible Book value grew to $ -5.14 per share from $ -5.31.

Company issued 13.69 million shares or 0.79 % in II. Quarter.
Interest Coverage Ratio was 3.43. Debt Coverage Ratio was 0.12.

More on ABT's Dividends
 Market Capitalization (Millions) 86,937
 Shares Outstanding (Millions) 1,749
 Total Debt (Millions $) 24,031
 Revenue (TTM) (Millions $) 23,607
 Net Income (TTM) (Millions $) 1,171
 Cash Flow (TTM) (Millions $) 7,097
 Capital Exp. (TTM) (Millions $) -1,158
 Dividend TTM ($) 1.05 $
 Dividend Yield TTM (%) 2.13 %
 Employees (TTM) $ 77,000


   

Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
TOMZ's Profile
Stock Price
TOMZ's Financials
TOMZ's Expectations
Business Description
Fundamentals
Charts & Quotes
TOMZ's News
Suppliers
TOMZ's Competitors
Customers & Markets
Economic Indicators
TOMZ's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com